New lung cancer drug takes on established treatment in Head-to-Head trial
Disease control
Terminated
This study aimed to see if a new drug called BAT3306 works similarly to the established drug Keytruda, when both are given with standard chemotherapy. It was for adults with advanced, non-squamous non-small cell lung cancer who had not received prior treatment. The main goal was …
Phase: PHASE3 • Sponsor: Bio-Thera Solutions • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC